We appreciate the interest of Dong et al. 1 in our recent publication and their thoughtful comments on future research directions for post-COVID-19 pulmonary sequelae 2.While we agree that quantitative CT, closer integration of imaging with clinical outcomes, artificial intelligence (AI)-assisted standardization, and refined radiological phenotyping may strengthen future prospective studies, these approaches were beyond the scope of our study, which was designed to provide a study-level metaanalysis of the currently available long-term follow-up literature.Their letter 1 suggested the use of quantitative CT descriptors and deep learning-based reconstruction algorithms to detect subtle parenchymal abnormalities.We
Song et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: